Trials / Completed
CompletedNCT00913120
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery
Phase II/III Study of YM150 - A Placebo-controlled, Double-blind, Group Comparison Study in Patients Undergoing Elective Total Hip Replacement Surgery
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 610 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the superiority of YM150 to the placebo and to evaluate the dose-dependent response of YM150 in patients undergoing elective total hip replacement surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YM150 | oral |
| DRUG | Placebo | oral |
| DRUG | Enoxaparin | injection |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2009-06-03
- Last updated
- 2010-06-09
Locations
16 sites across 4 countries: Japan, South Korea, Taiwan, Thailand
Source: ClinicalTrials.gov record NCT00913120. Inclusion in this directory is not an endorsement.